Alamar Biosciences, Inc.

NASDAQ:ALMR

Biotechnology

Healthcare
$30.51 +5.50%

+$1.11 today

Market cap
$2.12B
Beta
0.00
P/E (TTM)
-47.5
EPS (TTM)
-$0.45
52W Low $18.85High $27.20

Volume 0.53M

Average 0.38M

ALMR EBITDA Margin

EBITDA as a percentage of revenue.

Alamar Biosciences, Inc.NASDAQ: ALMR

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin at -40.6%

EBITDA Margin was -40.6% in Q2 FY2026.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of -33.5% for the fiscal year ending Dec 2026, up from -33.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
-40.6%+34.2 pp QoQ
Last fiscal yearDec 2025
-33.5%— YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year—+0.0 pp—
3 years—+0.0 pp—
5 years+0.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-33.5%
Year-over-year change
—
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ALMR compares with its peers on the latest reported figures

  • ALMR's FY2025 EBITDA Margin of -33.5% is the 4th highest of the 8 companies compared; the peer median is -66.6%.
ALMR Competitors Peer median
EBITDA Margin for ALMR and competitors
Company Period LTM level YoY 3-year change
TECHBio-Techne CorporationLTM Sep 202626.8% +8.6 pp-11.9 pp
TXG10x Genomics, Inc.LTM Sep 20266.1% +10.9 pp+25.5 pp
TWSTTwist Bioscience CorporationLTM Sep 2026-28.3% -14.5 pp+42.8 pp
ALMRAlamar Biosciences, Inc.FY2025-33.5% ——
PACBPacific Biosciences of California, Inc.LTM Mar 2026-66.6% +85.7 pp+198.6 pp
LABStandard BioTools Inc.LTM Mar 2026-94.5% -30.2 pp+72.1 pp
SEERSeer, Inc.LTM Mar 2026-427.9% +95.5 pp+175.4 pp
QSIQuantum-Si incorporatedLTM Mar 2026-5352.8% -2558.8 pp—
NAUTNautilus Biotechnology, Inc.FY2025— ——
Peer median (excluding ALMR) -66.6%+8.6 pp+57.4 pp

Competitors are the stored peer set for ALMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Alamar Biosciences, Inc.

NASDAQ:ALMR

Intrinsic Alpha fair value

Locked

Current Price

$30.51

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.